Innovation and technology projects
The Swiss Innovation Agency, Innosuisse, aims to promote science-based innovation in the interest of the economy and society in Switzerland.
Collapse all
-
Development of a senolytic of natural origin for anti-aging therapy
Grantee:
Andrea Alimonti
Duration:
12.2020 (18 months)
Title:
Development of a senolytic of natural origin for anti-aging therapy
Acronym/ID:
46608.1 IP-LS
We have identified a promising molecule, of natural origin, characterized by anti-aging properties. With this project, we will perform in vitro and in vivo experiments necessary for the development of an innovative anti-aging therapeutic intervention.
-
Development of a senolytic of natural origin for antiaging therapy
Grantee:
Andrea Alimonti
Duration:
11.2022 (18 months)
Title:
Development of a senolytic of natural origin for antiaging therapy
Acronym/ID:
103.496 IP-LS
We have identified a natural extract characterized by anti-aging properties, as well as the active ingredient responsible for its action. With this project, we will perform the experiments necessary for the development of innovative anti-aging nutraceutical supplements.
-
Evaluation of non-ATP competitive PI3Kδ inhibition with IOA-244 in the treatment of lymphoma
Grantee:
Francesco Bertoni
Duration:
08.2021 – 12.2023
Title:
Evaluation of non-ATP competitive PI3Kδ inhibition
with IOA-244 in the treatment of lymphoma
Acronym/ID:
55179.1 IP-LS
Inhibition of PI3Kδ is an established modality for the treatment of lymphoma. The proposed project will deliver mechanistic and efficacy information on iOnctura’s PI3Kδ inhibitor IOA-244, which has a novel mechanism of target inhibition.
